Thursday, October 10, 2013
Theravance to Report Third Quarter 2013 Financial Results on October 24, 2013
Friday, September 20, 2013
RELVAR™ ELLIPTA™ Gains Approval in Japan for the Treatment of Asthma
Thursday, September 19, 2013
RELVAR™ ELLIPTA™ Receives Positive Opinion From the CHMP in Europe for the Treatment of Asthma and COPD
Medicines that make a difference®
We apply our multivalency expertise to discover, develop and commercialize small molecule medicines for significant unmet medical needs.
We pursue a best-in-class strategy designed to discover superior medicines across multiple therapeutic areas.
We partner with pharmaceutical companies to accelerate development and commercialization of our product candidates.
Every day at Theravance, we think it through, find a way, and get it done so that together with our partners we can bring patients much needed new medicines.
Theravance discovers, develops and brings important medicines to patients by: